504
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells

, , , , , , , , & show all
Pages 232-235 | Published online: 12 Nov 2013

Figures & data

Figure 1. (A) Photomicrograph of Stat3 proteins expressed in HL-60 cells. (B) The control of secondary antibody only. Bar = 50 μm.

Figure 1. (A) Photomicrograph of Stat3 proteins expressed in HL-60 cells. (B) The control of secondary antibody only. Bar = 50 μm.

Figure 2. RT-PCR, western blot, and immunofluorescence staining showed that there was a reduction in the Stat3 expression level in the RNAi treatment group. (A) Results from RT-PCR. (B) Results from western blot. (C) Results from immunofluorescence staining. Bar = 50 μm.

Figure 2. RT-PCR, western blot, and immunofluorescence staining showed that there was a reduction in the Stat3 expression level in the RNAi treatment group. (A) Results from RT-PCR. (B) Results from western blot. (C) Results from immunofluorescence staining. Bar = 50 μm.

Figure 3. The effect of Stat3 RNAi on human leukemia HL-60 cell apoptosis was examined by using Annexin V assay. The statistical analysis showed that the apoptosis rate was increased after transfection with Stat3 shRNA (**P <0·01, ***P<0·001).

Figure 3. The effect of Stat3 RNAi on human leukemia HL-60 cell apoptosis was examined by using Annexin V assay. The statistical analysis showed that the apoptosis rate was increased after transfection with Stat3 shRNA (**P <0·01, ***P<0·001).

Figure 4. The effect of Stat3 RNAi on human leukemia HL-60 cell proliferation was examined by using MTS assay. The statistical analysis showed that the proliferation ability of HL-60 cells transfected with Stat3 shRNA was weakened (***P<0·001).

Figure 4. The effect of Stat3 RNAi on human leukemia HL-60 cell proliferation was examined by using MTS assay. The statistical analysis showed that the proliferation ability of HL-60 cells transfected with Stat3 shRNA was weakened (***P<0·001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.